
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime
Michael R. Jacobs, Ayman M. Abdelhamed, Caryn E. Good, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 9
Open Access | Times Cited: 3
Michael R. Jacobs, Ayman M. Abdelhamed, Caryn E. Good, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 9
Open Access | Times Cited: 3
Showing 3 citing articles:
Impact of porin deletions on cefepime-taniborbactam activity against Klebsiella pneumoniae
Tsuyoshi Uehara, Cassandra L. Chatwin, Brittany Miller, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
Tsuyoshi Uehara, Cassandra L. Chatwin, Brittany Miller, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten
Michael R. Jacobs, Caryn E. Good, Ayman M. Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access
Michael R. Jacobs, Caryn E. Good, Ayman M. Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access
Antibiorésistance et nouveaux antibiotiques, quoi de neuf ?
Maxime Renaux, Florian Blanchard
Oxymag (2024)
Closed Access
Maxime Renaux, Florian Blanchard
Oxymag (2024)
Closed Access